UBS’s PharMerica Corporation PMC Stock Holding History

UBS’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$2.88M	Buy	118,083 +25,476	+28%	+$676K	﹤0.01%	2569
2014 Q2	$2.65M	Buy	92,607 +53,163	+135%	+$1.48M	﹤0.01%	2605
2014 Q1	$1.1M	Sell	39,444 -1,946	-5%	-$47.8K	﹤0.01%	3394
2013 Q4	$890K	Sell	41,390 -4,917	-11%	-$89.4K	﹤0.01%	3674
2013 Q3	$614K	Buy	46,307 +12,560	+37%	+$169K	﹤0.01%	3903
2013 Q2	$467K	Buy	+33,747	New	+$478K	﹤0.01%	4171

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MCM

Munder Capital Management Birmingham, Michigan $13.4B AUM 18.35% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

UBS's PMC Position: Q3 2014 in Review

UBS increased its PharMerica Corporation (PMC) stake by 28% in Q3 2014, buying an estimated $676K and bringing the position to 118,083 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2569.

UBS first reported a position in PMC in Q2 2013 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold PMC as of Q3 2014.

UBS held 118,083 shares of PharMerica Corporation worth $2.88M as of Q3 2014.
UBS bought 25,476 PharMerica Corporation shares in Q3 2014, an estimated $676K.
PharMerica Corporation made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2569 holding.
UBS first reported a position in PharMerica Corporation in Q2 2013 and has held it in 6 quarters since.
161 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.